A groundbreaking study from the Indira Gandhi Agricultural University in Raipur indicates that a unique rice variety from Chhattisgarh, named ‘Sanjeevani,’ could be a key weapon in the fight against cancer. The research team, focusing on a nearly extinct rice strain from Bastar, discovered that the consumption of this rice may lead to the elimination of cancer cells. The findings are the result of extensive research, including tests at the Bhabha Atomic Research Centre, which showed promising results on mice. The Central Drug Research Institute has also verified the anti-cancer potential of Sanjeevani rice. Dr. Deepak Sharma and his team are preparing for human trials at the Tata Memorial Cancer Hospital, set to begin in January. This rice contains a rich profile of 213 biochemicals, with seven compounds specifically identified for their ability to combat cancer. These compounds trigger Nrf2, an antioxidant that works to counter the cellular damage that can lead to cancer development. Patients may need to consume a 10-gram dose of Sanjeevani rice daily. Experts note that this rice helps boost immunity. This discovery could lead to a new era in medicine, utilizing a rice variety with medicinal properties. Experts are hopeful that this medicinal use will be available in a few years. This research is the culmination of efforts in rice varietal research.